Showing results (21-30 of 724) with videos related to
Sort By:
Pageof 73
Cancer|October 24, 2013
HCVAD plus imatinib or dasatinib in lymphoid blastic phase chronic myeloid leukemiaPaolo Strati, Hagop Kantarjian, Deborah Thomas, et al.Clinical Lymphoma, Myeloma & Leukemia|August 24, 2013
Biological and clinical features of trisomy 21 in adult patients with acute myeloid leukemiaPaolo Strati, Naval Daver, Farhad Ravandi, et al.Leukemia & Lymphoma|August 10, 2013
Patient-driven discontinuation of tyrosine kinase inhibitors: single institution experienceOhad Benjamini, Hagop Kantarjian, Mary Beth Rios, et al.Blood|January 10, 2012
Improved survival in chronic myeloid leukemia since the introduction of imatinib therapy: a single-institution historical experienceHagop Kantarjian, Susan O'Brien, Elias Jabbour, et al.Oncotarget|May 3, 2017
Tumorigenesis promotes Mdm4-S overexpressionVinod Pant, Connie A Larsson, Neeraj Aryal, et al.Blood|May 6, 2006
Antileukemia activity of the combination of an anthracycline with a histone deacetylase inhibitorBlanca Sanchez-Gonzalez, Hui Yang, Carlos Bueso-Ramos, et al.Journal of Medical Economics|May 17, 2012
The economic burden of pleural effusions in patients with chronic myeloid leukemia treated with tyrosine kinase inhibitorsAnnie Guérin, Eric Q Wu, Vamsi K Bollu, et al.Current Opinion in Hematology|February 4, 2006
Overcoming drug resistance in chronic myeloid leukemiaJorge CortesHematology/Oncology Clinics of North America|July 24, 2004
Natural history and staging of chronic myelogenous leukemiaJorge CortesPageof 73